|« Previous month||Next month »|
28-Feb-2013 - Cedarburg Hauser says US CDMOs are focusing on “niche fields” in order to gain a competitive advantage on foreign competition.
28-Feb-2013 - Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry.
28-Feb-2013 - Profectus BioSciences has signed up San Diego-based CMO Althea Technologies to manufacture DNA vaccines after its deal with Boehringer Ingelheim ended due to currency issues.
28-Feb-2013 - Industry groups BIO and PhRMA are airing their discontents about US FDA draft guidance that could force sponsors to submit redundant clinical datasets for each trial site and waste time...
27-Feb-2013 - CRO Covance is teaming up with M2Gen’s cancer-focused database to increase its ability to match more patients in oncology trials based on their tumour profiles.
27-Feb-2013 - A South African and Lonza joint project says issues in funding, competitiveness and green technologies have delayed construction of its API plant.
27-Feb-2013 - Albemarle is adding new capacity at its manufacturing facility in Pennsylvania with a $30 million expansion.
27-Feb-2013 - Hospira has announced it is voluntarily recalling multiple lots of five different injections because of customer reports of faulty packaging and contamination.
26-Feb-2013 - GVK Biosciences says it is looking to target Taiwanese clients following a distribution deal with GGA over its clinical databases.
26-Feb-2013 - Eurofins, Illumina and McKesson have gone shopping and are showing off their new purchases – welcome to Outsourcing-Pharma.com’s acquisition round-up.
26-Feb-2013 - Ireland-based CRO Icon unveiled higher than expected revenue and backlog increases in 2012 when compared to 2011, and the company expects even stronger results in 2013.
25-Feb-2013 - West Pharmaceuticals says it is still intent on shifting to proprietary products following results from its packaging and contract manufacturing businesses.
25-Feb-2013 - Biopharmaceutical CMOs have seen their business slowly shrink as companies seek less volume and smaller batches, but outsourcing is expected to increase over the next three years.
25-Feb-2013 - Bend Research has partnered with its second chemistry major in six months, teaming up with BASF to develop bioavailability-boosting excipients.
25-Feb-2013 - Recipharm says taking on a contract started by another CMO is an exercise in building trust and gathering information as rapidly as possible.
21-Feb-2013 - Lonza has won a second US NIH contract to manufacture stem cells for medical research.
21-Feb-2013 - CiToxLAB says strong revenue growth in 2012 was due to a new global status following its acquisition of Lab Research.
21-Feb-2013 - Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry.
21-Feb-2013 - UK CMO Aesica claims its partnership with process innovation group Britest has already increased capacity without capital investment.
20-Feb-2013 - CMO ProBioGen says its GlymaxX ADCC antibody enhancement technology can be adapted to any biomanufacturing cell line and will attract both Big and Small Pharma.
20-Feb-2013 - CMOs (contract manufacturing organizations) developing pharmaceutical intermediates have shifted their focus to complex nucleosides, peptides and carbohydrates over the last five years, an expert says.
20-Feb-2013 - Almac says its newly approved laboratory will support US commercial launch of two new products.
19-Feb-2013 - Baxter says there is a trend towards outsourcing for cytotoxic manufacturing as it begins further expansion of its German plant.
19-Feb-2013 - Biocatalysis is emerging as a hot topic for CMOs in 2013 with AMRI, Almac and DSM all citing drug industry demand as the driver for recent collaborations.
19-Feb-2013 - In its second announcement of a closing research unit in little more than a week, Pfizer will axe its peptide therapeutic R&D unit CovX Research in San Diego, CA and...
|« Previous month||Next month »|